Peptides vs SARMs vs Steroids: Understanding the Differences
Peptides, SARMs, and anabolic steroids get sold by the same vendors and discussed in the same forums, but they work in different ways, carry different risks, and rest on very different amounts of evidence.
Steroids: decades of clinical data and FDA-approved uses. SARMs: Phase II trials, none approved, development mostly stalled. Peptides: ranges from Phase III (semaglutide) to a single mouse study, judged compound by compound.
- Covers
- how each class works, evidence quality by class, hormonal and organ risks, legal status
Why these get lumped together
The same online vendors sell all three. The same forums discuss all three. People take them for the same reasons: more muscle, less fat, faster recovery. And all three live in a regulatory gray zone unless a doctor prescribes them. So they blur into one category called “performance compounds.”
They are not one category. They act on different parts of the body, they have wildly different amounts of evidence behind them, and they do different things to your hormones. This guide is about those differences. It does not recommend any of them.
What each one actually is
Steroids
Anabolic steroids are lab-made versions of testosterone. They bind to androgen receptors, which sit in muscle, bone, skin, the prostate, the brain, and most other tissues, and they switch on protein building everywhere they land. That is why they add muscle and why they also cause acne, hair loss, breast tissue in men, and mood changes.
Several are approved drugs: testosterone itself, nandrolone, oxandrolone, for conditions like low testosterone, muscle wasting, and severe burns. Taken at bodybuilding doses, which run many times higher than medical doses, the risks scale up with them.
SARMs
SARMs, selective androgen receptor modulators, were designed to do what steroids do in muscle and bone while leaving the prostate, liver, and skin alone. Ostarine, ligandrol, RAD-140, and andarine are the common ones. They come as pills, which is a large part of their appeal.
The word “selective” is the goal, not the result. In trials, SARMs were less androgenic than steroids but not free of androgenic effects. They still suppress your own testosterone, and some produced liver and cholesterol signals that stopped their development. Several reached Phase II trials for muscle wasting. None has ever been approved, anywhere, and the pipeline has mostly gone quiet (Solomon et al., 2019).
One more thing: MK-677 is sold on the same shelves and constantly called a SARM. It is not one. It works on the ghrelin receptor to raise growth hormone and never touches the androgen receptor. This is one of the most common mix-ups in the space.
Peptides
Peptides are short chains of amino acids, usually 2 to 50, that act as signals in the body. That is a structural category, not a drug class. Comparing “peptides” to steroids is like comparing “proteins” to aspirin.
Some raise growth hormone (ipamorelin, CJC-1295). Some are studied for healing (BPC-157, TB-500). Some are approved weight-loss drugs (semaglutide, tirzepatide). Some work on the immune system (thymosin alpha-1). Most are injected, because the stomach digests them. Nearly all of them leave testosterone alone.
How much evidence each has
Steroids have the most. Testosterone and its relatives have decades of trials and approved medical uses. That they build muscle is not in question. That they damage the heart, liver, and hormone system at high doses is not in question either.
SARMs have the least finished. Phase II trials showed they add lean mass in people with muscle wasting. Then safety signals slowed everything, and the products now sold online are of uncertain identity: testing has repeatedly found the wrong compound, the wrong dose, or nothing at all in the bottle.
Peptides vary from the best evidence on this site to the worst. Semaglutide has trials with over 17,000 participants. BPC-157 has dozens of rat studies and no human trial. FOXO4-DRI has one mouse study. You have to judge each one on its own; the class tells you nothing.
What each does to your body
Steroids
Shut down natural testosterone, sometimes for good. Strain the heart: thicker heart walls, worse cholesterol, more clotting. Damage the liver, especially the oral kinds. Cause acne, hair loss, and breast growth in men. Change mood, and can be habit forming. All of it is dose dependent, and a medical dose is a different proposition from a bodybuilding dose.
SARMs
Suppress testosterone, confirmed in trials and dose dependent. Liver stress, from case reports and trial signals. Worse cholesterol. Unknown long-term effects, because no one has taken them long enough under observation. Plus whatever is actually in the bottle, which is a risk of its own.
Peptides
Depends entirely on which one. Growth hormone peptides can raise blood sugar, cause water retention, and carry a theoretical cancer concern from long-term IGF-1. Healing peptides have few reported side effects and almost no human safety data, which is not the same as being safe. GLP-1 drugs have well-mapped side effects from huge trials: nausea, gallbladder problems, muscle loss with the fat. As a group, peptides do not suppress testosterone and do not generally hurt the liver, which is the biggest practical difference from the other two classes. See the safety guide.
Legal status
Steroids are Schedule III controlled substances in the United States. Legal with a prescription for approved uses, illegal to possess without one in most places.
SARMs are not approved for human use anywhere and not scheduled as controlled substances in most countries, which puts them in a gray zone. The FDA has sent warning letters to companies selling them as supplements (FDA, 2017). WADA bans them.
Peptides depend on the compound. Approved ones like semaglutide and tesamorelin are prescription drugs. Research peptides sit in the same gray zone as SARMs, and the FDA has moved against some of them and against compounding pharmacies that make them. Growth hormone peptides are banned by WADA.
Frequently Asked Questions
Are peptides safer than steroids?
It depends which peptide and which steroid. Semaglutide has a safety profile mapped in tens of thousands of people. A research peptide with no human data has an unknown one. Testosterone at medical doses has decades of safety data. The question only means something when you name the two compounds.
Are SARMs “steroids lite”?
That framing is common and misleading. SARMs hit the same receptor as steroids with a promise of selectivity that trials did not fully deliver. They still suppress testosterone and still show liver signals. “Less studied” is closer to the truth than “less risky.”
Can peptides replace steroids for building muscle?
No. Growth hormone peptides like ipamorelin with CJC-1295 raise growth hormone and IGF-1, and the muscle gains in trials of that approach are modest. Steroids act directly on muscle protein synthesis and the results are in a different league. See the muscle growth guide.
Is MK-677 a SARM?
No. MK-677 raises growth hormone through the ghrelin receptor and has no effect on the androgen receptor. It gets shelved with SARMs by vendors, which is where the confusion comes from.
Which one shows up on a drug test?
Steroids are the easiest to detect. SARMs are detectable by anti-doping labs. Growth hormone peptides can be caught through blood markers such as the GH-to-IGF-1 ratio. Standard workplace panels test for none of these; sports testing is a different matter.
References
- Solomon ZJ, et al. (2019). Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications. Sex Med Rev. PubMed
- Bhasin S, et al. (2018). Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. PubMed
- FDA. (2017). FDA In Brief: FDA warns against using SARMs in body-building products. FDA.gov